People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

"The heavy ion radiotherapy is more accurate and less harmful to cancer patients," said Ye, explaining that, compared to X-rays, carbon ions cause less harm to normal cells when penetrating biological ...

Cambridge oncologist Raj Jena has been appointed the first Clinical Professor of AI in Radiotherapy in the UK. According to ...

Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for localized ...

The Global Robotic Radiotherapy Market, valued at approximately USD 1.1 billion in 2023, is anticipated to witness a robust growth trajectory with a compound annual growth rate (CAGR) of 11.9% over ...

Cambridge oncologist Raj Jena has been appointed the UK’s first Clinical Professor of AI in Radiotherapy. The creation of the new Cambridge University Clinical Professorship signals the importance of ...

Patients with EGFR-mutant, oligometastatic NSCLC who received radiotherapy plus icotinib had longer overall and ...

In the other 26% of cases, contrast MRI suggested lesion shrinkage while the MRI-linac scans showed lesion growth. Cullison ...

Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized ...

It means cancer patients could soon experience slower treatment and poorer patient experience, as ITV News' Health Correspondent Rebecca Barry reports. | ITV National News ...

Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

The Gauteng Department of Health (GDoH) says prostate and breast cancer patients will be assessed at Steve Biko Academic Hospital ...